Online inquiry

IVTScrip™ pT7-VEE-mRNA-Anti-IFNA1, RhuMAB IFNalpha Vector   (CAT#: GTVCR-WQ2407MR)

This product GTVCR-WQ2407MR is an effective transcription system suitable for a variety of research, including the in vitro translation, self-amplifying mRNA studies and protein expression. The system was driven by the T7 promoter to efficiently generate mRNA ecoding antibody which targeting IFNA1. The vector contains the self-replicating Venezuelan equine encephalitis (VEE) virus RNA replicon, which resulting the mRNA expression at a high level.

SPECIFIC INQUIRY

3' poly(A):
Inquiry
Specifications
Product type Vector
Promoter T7
Resistance Ampicillin
Species Humanized
RefSeq NM_024013.3
Applications IVT; Self-amplifying mRNA (SAM) research; Gene therapy research
Format Solution
Concentration 1 µg/µl
Quantity 10 µg
Target Gene
Gene ID 3439
UniProt ID P01562
Download
Download resources about mRNA therapeutics development to boost your research.
CUSTOMER REVIEWS and Q&As

There are currently no Customer reviews or questions for IVTScrip™ pT7-VEE-mRNA-Anti-IFNA1, RhuMAB IFNalpha Vector (GTVCR-WQ2407MR). Click the button above to contact us or submit your feedback about this product.

See other products
CAT Product Name Product Type CDs
GTVCR-WQ1109MR IVTScrip™ pSP6-VEE-mRNA-Anti-DPEP3, DC-1728001 Vector Vector DC-1728001
GTVCR-WQ1573MR IVTScrip™ pSP6-VEE-mRNA-Anti-IL2R, Interleukin 2 Vector Vector Interleukin 2
GTVCR-WQ1859MR IVTScrip™ pT7-VEE-mRNA-Anti-TNFRSF8, MDX-060 Vector Vector MDX-060
GTVCR-WQ1682MR IVTScrip™ pSP6-VEE-mRNA-Anti-FN, L19-131 I Vector Vector L19-131 I
GTVCR-WQ1672MR IVTScrip™ pSP6-VEE-mRNA-Anti-env, KD-247 Vector Vector KD-247
GTVCR-WQ1604MR IVTScrip™ pT7-VEE-mRNA-Anti-EGFR&MET, JNJ-61186372 Vector Vector JNJ-61186372
GTVCR-WQ470MR IVTScrip™ pSP6-VEE-mRNA-Anti-TNFSF11, AMG162 Vector Vector AMG162
GTVCR-WQ1074MR IVTScrip™ pT7-VEE-mRNA-Anti-Factor IX substitute, CSL654 Vector Vector CSL654
All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.